Another potential target is lymphocyte activation gene-3 (LAG-3, CD223), a co-inhibitory receptor able to suppress T-cell activation and cytokines secretion [115]; more specifically, LAG-3 overexpression in tumor cells is involved in the phenomenon of immune exhaustion, with suppression of T-cell function [116,117]. This evidence concerns the gene LAG3 and neoplasm.